Varied effects exerted on sudden sensorineural hearing loss through HBO2 therapeutic pressure.

This study aimed to compare the efficacy of two commonly used therapeutic pressures, 2.0 atmospheres absolute (ATA) versus 2.2 ATA, applied in hyperbaric oxygen (HBO2) therapy for sudden sensorineural hearing loss (SSNHL). We retrospectively reviewed the clinical records of 160 SSNHL patients treated by typical therapy or additional HBO2 therapy with pressure 2.0 or 2.2 ATA at Yijishan Hospital, the First Affiliated Hospital of Wannan Medical College, from February 2018 to May 2020. The pure-tone threshold audiometry results pre- and post-treatment were compared across three groups. In the range of frequencies 250-500 Hz, P2.0 (20.92±26.11 dB, p=0.047) and P2.2 group (20.47±±21.54 dB, p=0.012) both acquired higher hearing gain compared to the control group (11.94±23.32 dB). While in the range of frequencies 1,000-2,000 Hz, only the P2.2 group showed significant improvement of the hearing gain compared to the control group (19.70±21.13 dB vs.10.56±25.24 dB, p=0.015). In the range of frequencies 4,000-8,000, both the P2.0 and P2.2 groups failed to reach the desired effect. Our results suggest that the therapeutic effect is associated with HBO2 therapeutic pressure when applying HBO2 treatment combined with standard medical therapy. Within the range of appropriate pressure, the higher pressure, which means higher partial pressure of oxygen, has better therapeutic efficacy for SSNHL.